What Happened in April — and Why It Matters
On April 23, 2026, the Department of Justice issued an order placing state-licensed medical cannabis into Schedule III of the Controlled Substances Act. This was a landmark shift. For the first time, state-licensed medical operators are no longer subject to the infamous Section 280E tax provision — which had been disallowing normal business deductions and pushing effective federal tax rates for some operators as high as 70–90%.
That change is real and in effect now for qualifying medical operators.
But the April order drew a deliberate line: adult-use and recreational cannabis remained unchanged. The June 29 hearing is where that question formally opens.
What June 29 Could Mean
Three realistic outcomes from the June 29 hearing:
1. Broader rescheduling moves forward. If the administrative proceeding advances toward extending Schedule III status to adult-use cannabis, it would represent the most significant federal cannabis policy shift in decades. The downstream effects — on banking access, tax treatment, and insurance market participation — would unfold over months, not overnight.
2. The process continues with no immediate action. Administrative hearings frequently lead to extended comment periods and rulemaking timelines. A "no decision yet" outcome is likely, meaning adult-use operators remain in the same regulatory environment through the rest of 2026.
3. The hearing surfaces new restrictions or complications. Cannabis policy in 2026 is moving in both directions — rollback efforts have surfaced in Arizona and Massachusetts. Operators should plan for a range of outcomes.
What This Means for Your Insurance Program
Federal rescheduling does not automatically change your insurance coverage — policies don't rewrite themselves in response to a DOJ order. But several important dynamics are shifting.
More carriers are paying attention. Institutional counterparties, including some insurance carriers who previously avoided the cannabis market, are now treating Schedule III as a signal worth reconsidering. This may translate into expanded capacity options — more carriers willing to underwrite cannabis risk, which can mean more competition and potentially better terms. That said, underwriting decisions remain subject to individual carrier appetite and state-by-state review.
Mixed-use operations face new complexity. If your business has both a medical cannabis component and an adult-use component, the April order created a split situation that requires careful tracking. Your accounting, reporting, and coverage structures need to reflect which revenue streams qualify for 280E relief and which don't. Clean records aren't just good practice right now — they're necessary for defensible cost allocation if questions arise.
Coverage doesn't follow rescheduling automatically. Rescheduling acknowledges cannabis differently under federal law, but it does not mandate that insurers cover cannabis businesses or cannabis-specific losses. Your existing policies govern what's covered. If you haven't reviewed your program recently, now is the right time.
Three Things to Do Before July
1. Review your current coverage with your broker. Confirm that your policy limits, covered locations, and covered activities still match your current operations. If your business has grown — new locations, expanded product lines, transportation activity — your coverage should reflect that. All coverage is subject to underwriting approval.
2. Ask about market developments. If carriers are re-evaluating their cannabis appetite in light of rescheduling, there may be options available that weren't accessible twelve months ago. A conversation with a specialized cannabis insurance broker is worthwhile.
3. Document your business type clearly. Whether you're a medical-only operation, an adult-use operation, or a combined licensee matters for tax purposes — and it may increasingly matter for insurance underwriting as carriers develop more refined cannabis programs. Clear licensing documentation is an asset.
A Note on What Rescheduling Doesn't Do
It's worth being clear: Schedule III status does not resolve the fundamental tension between state cannabis law and federal law for adult-use operations. Cannabis remains a controlled substance under federal law for purposes not covered by the April order. Insurance for cannabis businesses remains specialized, state-by-state, and underwritten with that legal backdrop in mind. Rescheduling is a meaningful step — but it's not a compliance shortcut.
The June 29 hearing is another data point in a multi-year shift. Operators who stay informed and maintain well-structured insurance programs are better positioned to adapt, regardless of which direction federal policy moves.
Questions about your current cannabis insurance program? Our dedicated team works exclusively with cannabis businesses across our licensed states. Reach us at service@TheSpireTeam.com or 800-686-8664.
All coverage subject to underwriting approval. Policy terms and availability vary by state and operation type.
